Table 4.
Positive aPL antibodies in PAPS versus SAD-APS patients.
| Antibody | PAPS (n = 141) | SAD-APS (n = 15) | OR SAD-APS | P |
|---|---|---|---|---|
| aB2GPI IgG | 3 (2.1%) | 11 (73.3%) | 126.5 | <0.0001 |
| aB2GPI IgM | 5 (3.5%) | 3 (20%) | 6.8 | 0.0331 |
| aB2GPI IgA | 36 (21.9%) | 9 (60%) | 4.4 | 0.0124 |
| aCL IgG | 6 (4.2%) | 11 (73.3%) | 61.9 | <0.0001 |
| aCL IgM | 5 (3.5%) | 3 (20%) | 6.8 | 0.0331 |
| aCL IgA | 4 (2.8%) | 4 (26.7%) | 12.4 | 0.0008 |
| aB2GP1 IgA (isolated) | 33 (23.4%) | 2 (13.3%) | 0.5 | 0.5732 |
| aCL or aB2GPI (IgG or IgM) | 11 (7.8%) | 11 (73.3%) | 32.5 | <0.0001 |
| aCL or aB2GPI any isotype | 47 (33.3%) | 14 (93.3%) | 28.0 | <0.0001 |